| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |